ID: ALA5196334

Max Phase: Preclinical

Molecular Formula: C13H13BrO3

Molecular Weight: 297.15

Associated Items:

Representations

Canonical SMILES:  O=C(O)/C=C1\CCCc2ccc(Br)cc2C1O

Standard InChI:  InChI=1S/C13H13BrO3/c14-10-5-4-8-2-1-3-9(6-12(15)16)13(17)11(8)7-10/h4-7,13,17H,1-3H2,(H,15,16)/b9-6+

Standard InChI Key:  HTAMAYUCMQUSJV-RMKNXTFCSA-N

Associated Targets(non-human)

CaM kinase II alpha 109 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 297.15Molecular Weight (Monoisotopic): 296.0048AlogP: 2.83#Rotatable Bonds: 1
Polar Surface Area: 57.53Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.52CX Basic pKa: CX LogP: 2.93CX LogD: -0.44
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.62Np Likeness Score: 0.36

References

1. Tian Y, Shehata MA, Gauger SJ, Veronesi C, Hamborg L, Thiesen L, Bruus-Jensen J, Royssen JS, Leurs U, Larsen ASG, Krall J, Solbak SMØ, Wellendorph P, Frølund B..  (2022)  Exploring the NCS-382 Scaffold for CaMKIIα Modulation: Synthesis, Biochemical Pharmacology, and Biophysical Characterization of Ph-HTBA as a Novel High-Affinity Brain-Penetrant Stabilizer of the CaMKIIα Hub Domain.,  65  (22.0): [PMID:36346645] [10.1021/acs.jmedchem.2c00805]

Source